CLL is an indolent, mature lymphoproliferative malignancy characterised by a progressive accumulation of monoclonal B lymphocytes that coexpress CD5, CD19, CD23 and CD20 antigens in peripheral blood (PB), lymph nodes, spleen, and bone marrow (BM). The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.